Healthcare

MT-302, a TROP2-targeting mRNA-LNP in vivo CAR therapy, is the first treatment of its kind to move into a…

Dr Everlyn Banda LILONGWE, Malawi — The Public Health Institute of Malawi (PHIM), through its Research Division, will…

GSK’s outgoing chief executive, Emma Walmsley, has said Britain will struggle to be a “life sciences superpower” unless…

From stroke medications in Australia to ready-to-use cancer injections at home, Renata’s innovations reflect its mission to deliver…

People in the US shopping for health insurance through the Affordable Care Act marketplaces will face a steep…

Americans embarking on the annual task of sifting through the health plans offered by their employers to find…

Richard PriceWest Midlands Mid Cheshire Hospitals NHS Foundation Trust Nurses Ashleigh Hall and Kirstie Orr are leading the…

Phil Shepka,Cambridgeshire political reporter and Katy Prickett Orthopaedic Academy Kuldeep Stohr was investigated in relation to 700 planned…

CEO Agenda provides unique insights into how leaders think and lead and what keeps them busy in a…

There’s something compelling about pharmaceuticals, the business is never merely business. It directly impacts human health, affects families,…

Published on 28/10/2025 – 13:40 GMT+1 England is testing a new artificial intelligence (AI) tool to speed prostate…

In September, comedian Ate Gay revealed he had been diagnosed with stage 4 cancer. It started as a swelling…

CREATE Medicines and Amsterdam University Medical Center Initiate First In Vivo CAR Therapy Trial in Frontline Setting for Solid Tumors